Procter & Gamble beats estimates but guidance disappoints

Procter & Gamble (PG) reported Q1 earnings of $2.00 per share, beating estimates by $0.11, with revenue of $23.28 billion, up 4% YoY. However, its full-year guidance fell short of expectations, with core EPS guidance of $6.89-$7.11, below the $7.39 consensus. The company cited higher costs as a challenge. Shares rose 1.70% in pre-market trading.

Original reporting
Published Oct 22, 2026, 11:13 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PG
Bearish
high confidence
Mentioned
$PG
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PGBearishHigh
01

Why it matters

The guidance miss is a fresh, material data point for a large‑cap consumer staple, likely prompting a price correction.

02

Market read

Earnings beat with guidance shortfall creates immediate trading relevance for PG and may affect the consumer‑staples sector.

03

What to watch

Higher commodity costs and net interest expense may be temporary, and the Thorne acquisition could drive future growth.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Procter & Gamble posted Q1 earnings that beat estimates, but its FY2027 EPS guidance fell short of Wall Street expectations, highlighting cost pressures.

Company-level read

Ticker impact

$PGBearishHigh confidence
Context

PG reported Q1 earnings beat but full-year EPS guidance of $6.89‑$7.11 missed consensus of $7.39, prompting a 1.7% pre‑market rise then likely downside pressure.

Expected impact

likely pressure as the market prices in the guidance miss

Evidence & confidence

The earnings beat is offset by guidance below consensus, a material new data point for a large‑cap consumer staple.

Market effects

Consumer staples may see broader valuation pressure if guidance misses become a trend.

U.S. markets likely dip in consumer‑staples indices.

Limited; impact confined to U.S. and global consumer‑goods investors.

Counterpoint

The beat on earnings and strong cash flow could support a short‑term rally despite guidance miss.

Key entities

  • Procter & Gamble Co.

    Consumer goods conglomerate reporting Q1 results and FY guidance.

Related articles

$PGMed

P&G Plans To Cut Up To 30% Product Supply Jobs By 2030; Confirms FY27 Outlook

Procter & Gamble (P&G) plans to cut 20-30% of product supply jobs by 2030, aiming for $10B in productivity savings. The company maintained its FY27 outlook, projecting 2-4% net sales growth and 1-3% organic sales growth. P&G also expects $1.8B in annual productivity savings and $30B in growth opportunities. Shares gained 0.30% to $168.35 in overnight trading.

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November